Masahiko Kurokawa Selected Research

Masahiko Kurokawa Research Topics

Disease

20	Infections 01/2019 - 09/2002
10	Pneumonia (Pneumonitis) 01/2019 - 08/2005
9	Respiratory Syncytial Virus Infections 01/2019 - 01/2008
7	Human Influenza (Influenza) 09/2018 - 11/2002
6	Body Weight (Weight, Body) 01/2021 - 08/2003
6	Obesity 01/2021 - 07/2013
4	Hypersensitivity (Allergy) 05/2016 - 02/2003
2	Communicable Diseases (Infectious Diseases) 08/2021 - 02/2003
2	Insulin Resistance 01/2021 - 07/2013
2	Fever (Fevers) 09/2018 - 02/2010
2	Type 2 Diabetes Mellitus (MODY) 04/2017 - 07/2013
2	Inflammation (Inflammations) 07/2013 - 01/2013
2	Virus Diseases (Viral Diseases) 01/2013 - 04/2010
2	Myocarditis (Carditis) 06/2005 - 09/2002
1	Thrombosis (Thrombus) 09/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2021
1	Diabetes Mellitus 01/2021
1	Glucose Intolerance 01/2021
1	Common Cold 09/2018
1	Body Weight Changes 04/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2013
1	Hyperglycemia 07/2013
1	Melanoma (Melanoma, Malignant) 05/2010
1	Weight Loss (Weight Reduction) 02/2010
1	Herpes Simplex 12/2005
1	Neoplasms (Cancer) 12/2004
1	Cystitis 09/2004
1	Superinfection 01/2004
1	Chickenpox 12/2003
1	Septic Shock (Toxic Shock Syndrome) 08/2003

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2013 - 11/2002
5	Flame Retardants (Fire Retardants)IBA 01/2017 - 01/2008
5	InterferonsIBA 05/2016 - 01/2008
4	LactoferrinIBA 08/2021 - 03/2004
4	naringeninIBA 01/2020 - 07/2013
4	AntigensIBA 05/2016 - 02/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 08/2003
3	FlavonoidsIBA 09/2021 - 04/2017
3	tetrabromobisphenol AIBA 01/2017 - 04/2010
3	DiarylheptanoidsIBA 10/2013 - 01/2010
3	Propolis (Bee Bread)IBA 01/2013 - 01/2008
3	InterleukinsIBA 04/2010 - 11/2002
3	Acyclovir (Aciclovir)FDA LinkGeneric 12/2005 - 01/2004
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 04/2017
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020 - 07/2013
2	Chemokine CCL5IBA 01/2019 - 03/2015
2	LactoperoxidaseIBA 09/2018 - 08/2005
2	Interleukin-6 (Interleukin 6)IBA 01/2013 - 05/2010
2	Antiviral Agents (Antivirals)IBA 10/2010 - 12/2005
2	Oseltamivir (Tamiflu)FDA Link 10/2010 - 01/2008
2	phenyl etherIBA 05/2010 - 04/2010
2	LipopolysaccharidesIBA 05/2010 - 02/2010
2	Interleukin-12 (IL 12)IBA 04/2010 - 11/2002
2	Neutralizing AntibodiesIBA 06/2005 - 09/2002
2	Vidarabine (Vira-A)FDA Link 01/2005 - 09/2004
2	AntibodiesIBA 12/2004 - 08/2003
2	Chickenpox Vaccine (Vaccine, Varicella)IBA 12/2003 - 02/2003
1	Insulin (Novolin)FDA Link 01/2021
1	Therapeutic UsesIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Interferon Type IIBA 01/2019
1	TabletsIBA 09/2018
1	Pioglitazone (Actos)FDA Link 04/2017
1	PPAR gammaIBA 04/2017
1	AdipokinesIBA 04/2017
1	Methanol (Carbinol)IBA 07/2016
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 07/2016
1	titanium dioxide (Titania)FDA Link 03/2015
1	CosmeticsIBA 03/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2013
1	Interferon-gamma (Interferon, gamma)IBA 01/2013
1	methamidophosIBA 01/2013
1	InsecticidesIBA 01/2013
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 12/2011
1	tricinIBA 08/2011
1	Ethanol (Ethyl Alcohol)IBA 01/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2010
1	Pattern Recognition ReceptorsIBA 05/2010
1	Toll-Like Receptor 3IBA 05/2010
1	hexabromocyclododecaneIBA 04/2010
1	7-hydroxycoumarin (umbelliferone)IBA 02/2010
1	Propylthiouracil FDA Link 01/2008
1	Dihydrotachysterol (AT 10)IBA 01/2008
1	Thymidine KinaseIBA 12/2005
1	Phosphonoacetic Acid (Phosphonoacetate)IBA 12/2005
1	Immunoglobulins (Immunoglobulin)IBA 06/2005
1	CD30 LigandIBA 12/2004
1	CaspasesIBA 12/2004
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2004
1	Fas Ligand Protein (Fas Ligand)IBA 12/2004
1	LigandsIBA 12/2004
1	Death Domain ReceptorsIBA 12/2004
1	Milk Proteins (Milk Protein)IBA 03/2004
1	Glycoproteins (Glycoprotein)IBA 12/2003
1	Indicators and Reagents (Reagents)IBA 12/2003
1	DNA (Deoxyribonucleic Acid)IBA 08/2003
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2003
1	NF-kappa B (NF-kB)IBA 08/2003

Therapy/Procedure

7	Oral Administration 10/2016 - 11/2002
1	Therapeutics 09/2004